Novartis Expands US Innovation Footprint with USD 23 Billion R&D Push, Including New San Diego Research Hub

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including C...

February 09, 2026 | Monday | News
Forma Life Sciences Established Following Acquisition of BioDuro’s California Manufacturing Assets

BioSelective Capital Investments and Shayan Enterprises, LLC, a Utah-based risk-capital investment firm,  announced the successful acquisition of Bi...

February 06, 2026 | Friday | News
Cellares Expands Automation Platform into Gene-Edited HSC Therapies Through Stanford Medicine Collaboration

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), announced a collaboration with the Stanford Center for Definitive and C...

February 05, 2026 | Thursday | News
AGC Biologics Earns Anvisa GMP Certification to Support Global Commercialization of Customer Biologics

The Seattle facility of AGC Biologics, your friendly CDMO expert, has received a Good Manufacturing Practices Certification from Agência Nacional d...

February 05, 2026 | Thursday | News
Eli Lilly to Invest $3.5 Billion in Lehigh Valley Manufacturing Site for Next-Generation Weight-Loss Medicines

The $3.5 billion Lehigh Valley site will develop Lilly's next-generation weight-loss medicines, including retatrutide Company plans to create more than ...

February 03, 2026 | Tuesday | News
I Peace Establishes Human iPS Cells Derived From NKT Cells, Expanding Immune Cell Therapy Platform

Leading GMP cell therapy CDMO I Peace, Inc., specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that it ha...

February 03, 2026 | Tuesday | News
Ardena Completes Divestment of Södertälje API Site to Nanologica AB

Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, today announced that it has completed the dives...

February 02, 2026 | Monday | News
Takeda CEO Christophe Weber Says FY2025 Is “Pivotal” as Company Raises Outlook Despite VYVANSE Erosion

  Year-to-Date Revenue Declined by 2.8% at Constant Exchange Rate (CER), 3.3% atActual Exchange Rates (AER); Impact of VYVANSE® Generics is T...

February 02, 2026 | Monday | Company results
SK Capital to Divest Noramco API Assets to Siegfried as Halo Pharma Emerges as Stand-Alone Drug Product CDMO

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland) The...

January 29, 2026 | Thursday | News
Gannet BioChem Acquires Laysan Bio to Expand Activated Polymer and Bioconjugation Capabilities

Gannet BioChem, a leading specialty Contract Development and Manufacturing Organization (CDMO) backed by Boston-based private equity firm Ampersand Capit...

January 28, 2026 | Wednesday | News
HanchorBio and WuXi Biologics Enter Strategic Collaboration to Advance Next-Generation Fusion Proteins

HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseas...

January 27, 2026 | Tuesday | News
Syngene and Bristol Myers Squibb Extend Long-Standing Global R&D and Manufacturing Partnership

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), announced the extension of its long-standing stra...

January 23, 2026 | Friday | News
Onyx Scientific Expands Solid Form and Material Science Capabilities to Accelerate Complex Molecule Development

Onyx Scientific has announced the expansion of its solid form and material science screening capabilities in 2026, following the celebration of its 25th ...

January 21, 2026 | Wednesday | News
AGC Biologics’ Milan Cell and Gene Center Strengthens Global Leadership with Waskyra™ Approval

This further establishes the global leadership of AGC Biologics' Milan Cell and Gene Center of Excellence in number of commercial products approved ...

January 20, 2026 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close